Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Total Equity

Acadia Pharmaceutica Total Equity Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Total Equity from 2010 to 2020.
  • Acadia Pharmaceutica Total Equity for the quarter ending June 06, 2020 was $663m a -3.96% decrease of -26m year over year
  • Acadia Pharmaceutica Total Equity for the last 12 months ending June 06, 2020 was $663m a -3.96% decrease of -26m year over year
  • Acadia Pharmaceutica Annual Total Equity for 2019 was $699m a 31.48% increase of 220m from 2018
  • Acadia Pharmaceutica Annual Total Equity for 2018 was $479m a 30.01% increase of 144m from 2017
  • Acadia Pharmaceutica Annual Total Equity for 2017 was $335m a -54.62% decrease of -183m from 2016
Other Balance Sheet Metrics:
  • Acadia Pharmaceutica Total Assets for the quarter ending September 09, 2018 was $266m a -44.30% decrease of -118m year over year
  • Acadia Pharmaceutica Other Liabilities for the quarter ending December 12, 2018 was $2m a 49.81% increase of 1m year over year
View Chart On Koyfin

Quarterly ACAD Total Equity Data

06/2020$663m
03/2020$638m
12/2019$699m
09/2019$689m
06/2019$389m
03/2019$418m
12/2018$479m
09/2018$223m
06/2018$265m
03/2018$304m

Annual ACAD Total Equity Data

2019$699m
2018$479m
2017$335m
2016$518m
2015$200m
2014$309m
2013$182m
2012$85m
2011$23m
2010$30m